Open Save New
FeedNavigator / National Library of Health Sciences
 
  
Tutkijat / Institutions
AddAarnio, M(arkku) (KSSHP)
AddAlafuzoff, I. (Uppsala)
AddAro, A. (THL)
AddAromaa, A. (THL)
AddArvas, M(ikko) (Veripalvelu)
AddBamford, D.H. (UH Viikki Campus)
AddButcher, S. (UH Viikki Campus)
AddCerullo, V. (UH Viikki Campus)
AddEkblom-Kullberg, S(usanne) (Veripalvelu)
AddEskola, J. (THL)
AddFinel, M(oshe) (UH Viikki Campus)
AddGahmberg, C.G. (UH Viikki Campus)
AddHaimila, K(atri) (Veripalvelu)
AddHäkkinen, U. (THL)
AddHanski, I(lkka) (1953-2016) (UH Viikki Campus)
AddHari, R. (Aalto)
AddHavulinna, A(ki) S. (THL)
AddHemminki, E. (THL)
AddHiltunen, L(eena) (Veripalvelu)
AddHiltunen, R(aimo) (UH Viikki Campus)
AddHolthöfer, H. (CBAS, Dublin)
AddHovi, T. (THL)
AddHuoponen, O(uti) (Veripalvelu)
AddHuovinen, P. (THL)
AddHyytiä, P. (THL)
AddImpola, U(lla) (Veripalvelu)
AddJaatinen, T(aina) (Veripalvelu)
AddJacobs, H.T. (UH Viikki Campus)
AddJalanko, A. (THL)
AddJalkanen, J(yrki) (KSSHP)
AddJantunen, M. (THL)
AddJavela, K(aija) (Veripalvelu)
AddJoensuu, T(imo) (Docrates Cancer Center)
AddJokela, J(orma) (Laurea)
AddJokitalo, E. (UH Viikki Campus)
AddJousilahti, P(ekka) (THL)
AddJulkunen, I. (THL)
AddJuppo, A(nne) (UH Viikki Campus)
AddKääriäinen, H. (THL)
AddKaartinen, T(anja) (Veripalvelu)
AddKairemo, K(alevi) (Docrates)
AddKallioniemi, O(lli) (SciLifeLab)
AddKarvonen, M. (THL)
AddKayhty, H. (THL)
AddKerkelä, E(rja) (Veripalvelu)
AddKeskimäki, I. (THL)
AddKiianmaa, K. (THL)
AddKinnunen, P.K. (Aalto)
AddKirjavainen, V(esa) (Veripalvelu)
AddKlaukka, T. (Kela)
AddKorhonen, M(atti) (Veripalvelu)
AddKoskela, S(atu) (Veripalvelu)
AddKoskinen, S(eppo) (THL)
AddKovanen, P.T. (Wihuri)
AddKyrölä, K(ati) (KSSHP)
AddLaatikainen, T(iina) (THL)
AddLähteenmäki, K(aarina) (Veripalvelu)
AddLaitinen, S(aara) (Veripalvelu)
AddLappalainen, P. (UH Viikki Campus)
AddLarjo, A(ntti) (Veripalvelu)
AddLauronen, J(ouni) (Veripalvelu)
AddLehtinen, M(atti) (THL)
AddLeino-Arjas, P. (TTL)
AddLeinonen, M. (THL)
AddLindros, K. (THL)
AddLinjama, T(iina) (Veripalvelu)
AddLönnqvist, J. (THL)
AddMäkelä, M. (THL)
AddMäkelä, P.H. (THL)
AddMalmivaara, A(ntti) (THL)
AddMännistö, P. (UH Viikki Campus)
AddMattila, P. (PSHP)
AddMattila, P(irkko) (Veripalvelu/FIMM)
AddMättö, J(aana) (Veripalvelu)
AddNatunen, S(uvi) (Veripalvelu)
AddNissinen, A. (THL)
AddNystedt, J(ohanna) (Veripalvelu)
AddOvaskainen. M.L (THL).
AddPalosuo, T. (THL)
AddPalva, A(iri) (UH Viikki Campus)
AddPartanen, J(ukka) (Veripalvelu)
AddPartonen, T. (THL)
AddPatja, K. (THL)
AddPeltonen, M(arkku) (THL)
AddPeräsaari, J(uha) (Veripalvelu)
AddPietinen, P. (THL)
AddPrattala, R. (THL)
AddPuska, P. (THL)
AddQiao, Q(ing) (THL)
AddReunanen, A. (THL)
AddRiihimäki, H. (TTL)
AddRitari, J(armo) (Veripalvelu)
AddRuotsalainen, P. (THL)
AddRuskoaho, H(eikki) (UH Viikki Campus)
AddRuutu, P. (THL)
AddSaarma, M. (UH Viikki Campus)
AddSaarni, S.I. (THL)
AddSaikku, P. (THL)
AddSainio, S(usanna) (Veripalvelu)
AddSalomaa, V(eikko) (THL)
AddShimmi, O. (UH Viikki Campus)
AddSiitonen, A. (THL)
AddSolantaus, T. (THL)
AddThesleff, I. (UH Viikki Campus)
AddTuomisto, J. (THL)
AddUutela, A. (THL)
AddVaarala, O. (THL)
AddValsta, L. (THL)
AddVartiainen, E(rkki) (THL)
AddVartiainen, T. (THL)
AddVasankari, T(ommi) (UKK)
AddViikari-Juntura, E. (TTL)
AddVirtamo, J. (THL)
AddVirtanen, S.M. (THL)
AddVuopio, J. (THL)
AddWahlbeck, K. (THL)
AddWikström, M. (UH Viikki Campus)

Scholar Chart >>



»My Articles

»Latest Feeds

»Popular Feeds
Search Feed Catalog by Name:
Preterm birth rate after bivalent HPV vaccination: Registry-based follow-up of a randomized clinical trialLehtinen, M(atti) (THL)47 dayssaveRefWorksSFX Info
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccinesLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from FinlandLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
The EACTS Residents CommitteeLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European CountriesLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Sustained Cross-Reactive Antibody Responses After Human Papillomavirus Vaccinations: Up To 12 Years Follow-Up In The Finnish Maternity CohortLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Efficacy of AS04-adjuvanted HPV-16/18 vaccine against clearance of incident HPV infections: Pooled analysis of data from the CVT and PATRICIA randomized trialsLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
ESTIMATION OF HP(3) AMONG STAFF MEMBERS IN TWO NUCLEAR MEDICINE UNITS IN FINLANDLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
The Age-Specific Cervical Cancer Incidence Differs Between Human Papillomavirus Types: Implications for Predicting the Impact of Elimination ProgramsLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomised HPV vaccination trial with moderate coverageLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Impact of HPV vaccination on cervical screening performance: a population-based cohort studyLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE projectLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is AppliedLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccinesLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Human papillomavirus genotype replacement: still too early to tell?Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 yearsLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
The Prevalence of HSV, HHV-6, HPV and <em>Mycoplasma genitalium</em> in <em>Chlamydia trachomatis</em> positive and <em>Chlamydia trachomatis</em> Negative Urogenital Samples among Young Women in FinlandLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated womenLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females-Results from a community-randomized trialLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort studyLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated womenLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective studyLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Fast approximate computation of cervical cancer screening outcomes by a deterministic multiple-type HPV progression modelLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policiesLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Superselective endovascular tissue access using trans-vessel wall technique: feasibility study for treatment applications in heart, pancreas and kidney in swineLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Long-term Antibody Response to Human Papillomavirus Vaccines: Up to 12 Years of Follow-up in the Finnish Maternity CohortLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Which human papillomavirus vaccine and vaccination strategy for national programs?Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Gender-neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Estimating effectiveness of HPV vaccination against HPV infection from post-vaccination data in the absence of baseline dataLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Potential occupational exposures in diagnostic and interventional radiology: statistical modeling based on Finnish national dose registry dataLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
The risk of cervical atypia in oral contraceptive usersLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Vaccination protects against invasive HPV-associated cancersLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Cancer Registry follow-up for 17 million person-years of a nationwide maternity cohortLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Human Papillomavirus (HPV) Prevalence in Male Adolescents 4 Years After HPV-16/18 VaccinationLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling StudyLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Universal Janus Filters for the Rapid Separation of Oil from Emulsions Stabilized by Ionic or Nonionic SurfactantsLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of <em>three cohorts from randomized trials</em>Lehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort ConsortiumLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort ConsortiumLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Evaluation of Type Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two Randomized TrialsLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Safety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12-15 years: Interim analysis of a large community-randomized controlled trialLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity CohortLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine GenotypesLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trialLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Hormone concentrations throughout uncomplicated pregnancies: a longitudinal studyLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
Population-Based Study of Prediagnostic Antibodies to Chlamydia trachomatis in Relation to Adverse Pregnancy OutcomeLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
EXPERIENCES IN DEVELOPING A NATIONAL DOSE REGISTER IN FINLAND AND MERGING IT WITH THE OVERALL SUPERVISORY DATA SYSTEMLehtinen, M(atti) (THL)55 dayssaveRefWorksSFX Info
 XML / RSS feed
report
next »